Newly-released Orthopedic Navigation Systems Market analysis report by Future Market Insights shows that global sales of the Orthopedic Navigation Systems Market in 2022 were held at US$ 2.4 Billion. With a CAGR of 16.9% from 2023 to 2033, the market is projected to reach a valuation of US$ 13.2 Billion. Orthopedic navigation systems for Knee is expected to be the highest revenue-generating segment, accounting for an expected CAGR rate of 19.1% from 2023 to 2033.
Attribute | Details |
---|---|
Global Orthopedic Navigation Systems Market (2023) | US$ 2.8 Billion |
Global Orthopedic Navigation Systems Market (2033) | US$ 13.2 Billion |
Global Orthopedic Navigation Systems Market CAGR (2023 to 2033) | 16.9% |
USA Orthopedic Navigation Systems Market CAGR (2023 to 2033) | 17.6% |
Key Companies Profiled |
|
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
As per the Orthopedic Navigation Systems Market research by Future Market Insights - a market research and competitive intelligence provider, historically, from 2018 to 2022, the market increased at around 15% CAGR.
More than a decade ago, orthopedic navigation systems were first employed in orthopedic spinal surgery to improve the efficiency of pedicle screw insertion. It has now received widespread acceptance among orthopedic surgeons and has shown to be a useful tool in a variety of orthopedic operations, including reconstructive hip and knee surgery, sports injury, trauma, spine surgery, and tumor surgery.
Orthopedic navigation systems are developed to provide surgeons with real-time input on the surgical field, allowing them to change surgical approaches in order to improve postoperative outcomes and reduce intraoperative errors. Furthermore, classic and conventional approaches may lack accuracy, precision, and repeatability. As a result, there is a greater need for the creation of a revolutionary orthopedic navigation system.
Over the forecast years, the market is expected to rise due to an increase in the senior population and cases of joint reconstruction, rising healthcare expenditure, and high levels of awareness among patients and healthcare professionals. The prevalence of orthopedic disorders such as osteoarthritis, osteoporosis, ligamentous knee injuries, and rheumatoid arthritis, is on the rise.
Muscles, bones, joints, nerves, ligaments, cartilage, and tendons are all part of the musculoskeletal system, which includes bones, muscles, nerves, joints, ligaments, tendons, and cartilage. This causes a loss in the range of motion, stiffness, edema, and muscle soreness, which necessitates surgical intervention later.
Factors such as the rising use of minimally invasive surgical procedures, the increasing number of mergers and acquisitions among market participants, and the rising incidence of orthopedic and neurological illnesses are driving the orthopedic navigation systems market.
Increasing financing initiatives from the government for surgical navigation system research and development is also contributing to market growth. The high cost of surgical navigation systems and product recalls, on the other hand, are anticipated to have a negative impact on the orthopedic navigation systems market's growth.
Businesses are concentrating on raising knowledge about the use and benefits of orthopedic navigation systems among healthcare professionals and patients. In developed countries, manufacturers of surgical navigation systems have begun to reach out to local communities by offering CME classes. As a result, physicians and experts are becoming more aware of the availability and use of orthopedic navigation systems. Furthermore, commercially marketed orthopedic navigation systems come with a six to seven-year warranty, resulting in a seven-year product sales cycle. As a result of the increased demand for technology aid in orthopedic treatments, the market for orthopedic navigation systems is likely to expand throughout the forecast period.
Several innovative technologies are currently projected to impact the market in the near future. As a result, in the next seven years, hospitals are more likely to hunt for better alternatives. Owing to this, hospitals can avoid purchasing an orthopedic navigation system multiple times. Due to this, orthopedic navigation system providers are unable to reach new clients, hampering market expansion.
It is likely that one of the primary factors projected to boost the growth and demand of the orthopedic navigation systems market is the increased use of navigation software by physicians and surgeons due to the availability of cost-effective solutions. Furthermore, from 2023 to 2033, the rising adoption of minimally invasive operations and increased awareness are likely to contribute to the global market's growth.
The rising rate of obesity-related disorders and the large numbers of patients who value computer-assisted surgery will drive market growth. In addition, the launch of the new technology is predicted to fuel the expansion of the high-growth zone of the additional joint reconstruction market.
In the forecast period of 2023 to 2033, rapid technological advances in surgical navigation systems, the acquisition of capital for research and development activities, and growth in the incidence of osteoarthritis are expected to provide lucrative opportunities for the orthopedic navigation systems market.
In 2022, North America accounted for a significant revenue share due to favorable government measures promoting orthopedic navigation systems. Furthermore, factors such as an aging population, high government healthcare spending, a well-developed reimbursement mechanism, and the existence of established manufacturers in the region all contribute to regional market growth.
The high rate of occurrence of osteoarthritis in countries, as well as technical improvements in the United States, have contributed to the growth of the orthopedic navigation systems market in North America.
Between 2012 and 2018, 1,525,435 primary and revision hip and knee arthroplasty surgeries were performed, according to the 2019 American Joint Replacement Registry Annual Report. With 55.1% and 33.1%, most surgeries were for the primary knee and primary hip, respectively. The average age of a hip arthroplasty patient was 67.4 years, whereas the average age of all knee arthroplasty patients was 66.7 years, indicating the patient population in North America.
USA accounts for a significant share of the market and is expected to account for a valuation of US$ 5.2 Billion by 2033. Complete knee arthroplasty, total hip arthroplasty, anterior cruciate ligament restoration, trauma, and corrective surgeries use orthopedic imaging-guided surgical systems.
The positioning of the orthopedic implant is critical throughout these repair surgeries. Despite being dominated by a few well-established companies, the industry in the United States continues to grow thanks to surgeons and medical institutes promoting applications for the spine, nose and throat, and orthopedics.
The market in the United Kingdom is expected to reach a valuation of US$ 1.1 Billion by 2033. Growing with a CAGR of 15.2% in the forecast period, the market in the country is projected to garner an absolute dollar opportunity of around US$ 715.9 Million.
In Japan, the market is expected to grow at a CAGR of 19.2% from 2023 to 2033, reaching around US$ 539 Million by 2033. The market in the country is expected to gross an absolute dollar opportunity of US$ 444.6 Million during the forecast period.
The market in South Korea is expected to reach a valuation of around US$ 207 Million by 2033, growing at a CAGR of 12% from 2023 to 2033. The market in the country is expected to witness an absolute dollar opportunity of around US$ 142.3 Million.
The market revenue through Knee application is expected to account for a CAGR of 19.1% during the forecast period. Rising awareness pertaining to the advantages associated with total knee replacement procedures and improved patient well-being has resulted in the rise of total knee replacement procedures.
Segment growth on multiple surgical fronts can be credited to increasing applications of total knee arthroplasty, unicompartmental knee replacement, kneecap replacement, and revision knee replacement procedures.
Advancements in medical technology, such as the development of minimally invasive operations, and the increased availability of superior implant materials are likely to drive the increased volume of knee-replacement operations, boosting segment growth.
Knee replacement surgeries have increased globally due to the rising incidence of knee disorders and growing unhealthy lifestyles. Additionally, the use of orthopedic navigation as well as surgical techniques that could speed up navigation is likely to accelerate the need for navigation systems in knee replacement surgeries.
Optical orthopedic navigation systems hold a prominent market share and are expected to account for a CAGR of 16.7% from 2023 to 2033. Since Optical Navigation Systems are easy to handle and manage Intra operative instances as compared to conventional surgical systems. Furthermore, these systems operate at maximum precision and are more reliable.
This has improved surgical technical operations and paved the way for more complex treatments. When compared to older surgical systems, an optical surgical navigation system is simple to use. Furthermore, it is based on a highly precise stereo-vision approach. These systems are used in medical treatments that need a high level of precision and several access points. The expansion of the segment can be attributable to such technological advantages.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The key players operating in Orthopedic Navigation Systems Market include Stryker, Medtronic, Johnson & Johnson Services, B. Braun Melsungen AG, Smith + Nephew, OrthAlign, Globus Medical, and Zimmer Biomet.
Similarly, recent developments related to companies offering Orthopedic Navigation Systems have been tracked by the team at Future Market Insights, which are available in the full report.
The market is valued at US$ 2.8 billion in 2023.
The market is estimated to flourish at a 16.9% CAGR through 2033.
Japan to surge at a CAGR of 19.2% through 2033.
Top market players are Stryker, Medtronic, and Johnson & Johnson Services.
The market is estimated to reach US$ 13.2 billion in 2033.
1. Executive Summary | Orthopedic Navigation Systems Market 1.1. Global Market Outlook 1.2. Summary of Statistics 1.3. Key Market Characteristics & Attributes 1.4. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Risks and Trends Assessment 3.1. Risk Assessment 3.1.1. COVID-19 Crisis and Impact on Market 3.1.2. COVID-19 Impact Benchmark with Previous Crisis 3.1.3. Impact on Market Value (US$ Bn) 3.1.4. Assessment by Key Countries 3.1.5. Assessment by Key Market Segments 3.1.6. Action Points and Recommendation for Suppliers 3.2. Key Trends Impacting the Market 3.3. Formulation and Product Development Trends 4. Market Background 4.1. Market, by Key Countries 4.2. Market Opportunity Assessment (US$ Bn) 4.2.1. Total Available Market 4.2.2. Serviceable Addressable Market 4.2.3. Serviceable Obtainable Market 4.3. Market Scenario Forecast 4.3.1. Demand in optimistic Scenario 4.3.2. Demand in Likely Scenario 4.3.3. Demand in Conservative Scenario 4.4. Investment Feasibility Analysis 4.4.1. Investment in Established Markets 4.4.1.1. In Short Term 4.4.1.2. In Long Term 4.4.2. Investment in Emerging Markets 4.4.2.1. In Short Term 4.4.2.2. In Long Term 4.5. Forecast Factors - Relevance & Impact 4.5.1. Top Companies Historical Growth 4.5.2. Growth in Automation, By Country 4.5.3. Markets Adoption Rate, By Country 4.6. Market Dynamics 4.6.1. Market Driving Factors and Impact Assessment 4.6.2. Prominent Market Challenges and Impact Assessment 4.6.3. Markets Market Opportunities 4.6.4. Prominent Trends in the Global Market & Their Impact Assessment 5. Key Success Factors 5.1. Manufacturers’ Focus on Low Penetration High Growth Markets 5.2. Banking on with Segments High Incremental Opportunity 5.3. Peer Benchmarking 6. Global Market Demand Analysis 2018 to 2022 and Forecast, 2023 to 2033 6.1. Historical Market Analysis, 2018 to 2022 6.2. Current and Future Market Projections, 2023 to 2033 6.3. Y-o-Y Growth Trend Analysis 7. Global Market Value Analysis 2018 to 2022 and Forecast, 2023 to 2033 7.1. Historical Market Value (US$ Bn) Analysis, 2018 to 2022 7.2. Current and Future Market Value (US$ Bn) Projections, 2023 to 2033 7.2.1. Y-o-Y Growth Trend Analysis 7.2.2. Absolute $ Opportunity Analysis 8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Application 8.1. Introduction / Key Findings 8.2. Historical Market Size (US$ Bn) Analysis By Application, 2018 to 2022 8.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Application, 2023 to 2033 8.3.1. Knee 8.3.2. Hip 8.3.3. Spine 8.4. Market Attractiveness Analysis By Application 9. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Technology 9.1. Introduction / Key Findings 9.2. Historical Market Size (US$ Bn) Analysis By Technology, 2018 to 2022 9.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Technology, 2023 to 2033 9.3.1. Electromagnetic 9.3.2. Optical 9.3.3. Other Technologies 9.4. Market Attractiveness Analysis By Technology 10. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End-use 10.1. Introduction / Key Findings 10.2. Historical Market Size (US$ Bn) Analysis By End-use, 2018 to 2022 10.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By End-use, 2023 to 2033 10.3.1. Dermatology 10.3.2. Drug Delivery 10.3.3. Pain Management 10.3.4. Cancer Therapy 10.3.5. Vaccine Delivery 10.3.6. Other Applications 10.4. Market Attractiveness Analysis By End-use 11. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 11.1. Introduction 11.2. Historical Market Size (US$ Bn) Analysis By Region, 2018 to 2022 11.3. Current Market Size (US$ Bn) & Analysis and Forecast By Region, 2023 to 2033 11.3.1. North America 11.3.2. Latin America 11.3.3. Europe 11.3.4. Asia Pacific 11.3.5. Middle East and Africa (MEA) 11.4. Market Attractiveness Analysis By Region 12. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033 12.1. Introduction 12.2. Pricing Analysis 12.3. Historical Market Size (US$ Bn) Trend Analysis By Market Taxonomy, 2018 to 2022 12.4. Market Size (US$ Bn) & Forecast By Market Taxonomy, 2023 to 2033 12.4.1. By Country 12.4.1.1. USA 12.4.1.2. Canada 12.4.2. By Application 12.4.3. By Technology 12.4.4. By End-use 12.5. Market Attractiveness Analysis 12.5.1. By Country 12.5.2. By Technology 12.5.3. By Application 12.5.4. By End-use 13. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033 13.1. Introduction 13.2. Pricing Analysis 13.3. Historical Market Size (US$ Bn) Trend Analysis By Market Taxonomy, 2018 to 2022 13.4. Market Size (US$ Bn) & Forecast By Market Taxonomy, 2023 to 2033 13.4.1. By Country 13.4.1.1. Brazil 13.4.1.2. Mexico 13.4.1.3. Rest of Latin America 13.4.2. By Application 13.4.3. By Application 13.4.4. By Application 13.5. Market Attractiveness Analysis 13.5.1. By Country 13.5.2. By Technology 13.5.3. By Application 13.5.4. By Application 14. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033 14.1. Introduction 14.2. Pricing Analysis 14.3. Historical Market Size (US$ Bn) Trend Analysis By Market Taxonomy, 2018 to 2022 14.4. Market Size (US$ Bn) & Forecast By Market Taxonomy, 2023 to 2033 14.4.1. By Country 14.4.1.1. Germany 14.4.1.2. France 14.4.1.3. United kingdom 14.4.1.4. Italy 14.4.1.5. Spain 14.4.1.6. Russia 14.4.1.7. Rest of Europe 14.4.2. By Application 14.4.3. By Technology 14.4.4. By End-use 14.5. Market Attractiveness Analysis 14.5.1. By Country 14.5.2. By Technology 14.5.3. By Application 14.5.4. By Technology 15. Asia Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033 15.1. Introduction 15.2. Pricing Analysis 15.3. Historical Market Size (US$ Bn) Trend Analysis By Market Taxonomy, 2018 to 2022 15.4. Market Size (US$ Bn) & Forecast By Market Taxonomy, 2023 to 2033 15.4.1. By Country 15.4.1.1. China 15.4.1.2. Japan 15.4.1.3. South Korea 15.4.1.4. India 15.4.1.5. Australia 15.4.1.6. Rest of Asia Pacific 15.4.2. By Application 15.4.3. By Technology 15.4.4. By End-use 15.5. Market Attractiveness Analysis 15.5.1. By Country 15.5.2. By Technology 15.5.3. By Application 15.5.4. By End-use 16. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033 16.1. Introduction 16.2. Pricing Analysis 16.3. Historical Market Size (US$ Bn) Trend Analysis By Market Taxonomy, 2018 to 2022 16.4. Market Size (US$ Bn) & Forecast By Market Taxonomy, 2023 to 2033 16.4.1. By Country 16.4.1.1. Saudi Arabia 16.4.1.2. South Africa 16.4.1.3. Israel 16.4.1.4. UAE 16.4.1.5. Rest of Middle East and Africa 16.4.2. By Application 16.4.3. By Technology 16.4.4. By End-use 16.5. Market Attractiveness Analysis 16.5.1. By Country 16.5.2. By Technology 16.5.3. By Application 16.5.4. By End-use 17. Key Countries Market Analysis 2018 to 2022 and Forecast 2023 to 2033 17.1. Introduction 17.1.1. Market Value Proportion Analysis, By Key Countries 17.1.2. Global Vs. Country Growth Comparison 17.2. US Market Analysis 17.2.1. Value Proportion Analysis by Market Taxonomy 17.2.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2033 17.2.2.1. By Application 17.2.2.2. By Technology 17.2.2.3. By End-use 17.3. Canada Market Analysis 17.3.1. Value Proportion Analysis by Market Taxonomy 17.3.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2033 17.3.2.1. By Technology 17.3.2.2. By Application 17.3.2.3. By End-use 17.4. Mexico Market Analysis 17.4.1. Value Proportion Analysis by Market Taxonomy 17.4.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2033 17.4.2.1. By Application 17.4.2.2. By Technology 17.4.2.3. By End-use 17.5. Brazil Market Analysis 17.5.1. Value Proportion Analysis by Market Taxonomy 17.5.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2033 17.5.2.1. By Technology 17.5.2.2. By Application 17.5.2.3. By End-use 17.6. Germany Market Analysis 17.6.1. Value Proportion Analysis by Market Taxonomy 17.6.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2033 17.6.2.1. By Application 17.6.2.2. By Technology 17.6.2.3. By End-use 17.7. France Market Analysis 17.7.1. Value Proportion Analysis by Market Taxonomy 17.7.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2033 17.7.2.1. By Application 17.7.2.2. By Technology 17.7.2.3. By End-use 17.8. Italy Market Analysis 17.8.1. Value Proportion Analysis by Market Taxonomy 17.8.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2033 17.8.2.1. By Application 17.8.2.2. By Application 17.8.2.3. End-use 17.9. India Market Analysis 17.9.1. Value Proportion Analysis by Market Taxonomy 17.9.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2033 17.9.2.1. By Application 17.9.2.2. By Technology 17.9.2.3. By End-use 17.10. UK Market Analysis 17.10.1. Value Proportion Analysis by Market Taxonomy 17.10.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2033 17.10.2.1. By Technology 17.10.2.2. By End-use 17.10.2.3. By Application 17.11. Australia Market Analysis 17.11.1. Value Proportion Analysis by Market Taxonomy 17.11.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2033 17.11.2.1. By Application 17.11.2.2. By Technology 17.11.2.3. By End-use 17.12. China Market Analysis 17.12.1. Value Proportion Analysis by Market Taxonomy 17.12.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2033 17.12.2.1. By Application 17.12.2.2. By Technology 17.12.2.3. By End-use 17.13. Japan Market Analysis 17.13.1. Value Proportion Analysis by Market Taxonomy 17.13.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2033 17.13.2.1. By Application 17.13.2.2. By Technology 17.13.2.3. By End-use 17.14. South Korea Market Analysis 17.14.1. Value Proportion Analysis by Market Taxonomy 17.14.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2033 17.14.2.1. By Application 17.14.2.2. By Technology 17.14.2.3. By End-use 17.15. Israel Market Analysis 17.15.1. Value Proportion Analysis by Market Taxonomy 17.15.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2033 17.15.2.1. By Application 17.15.2.2. By Technology 17.15.2.3. By End-use 17.16. South Africa Market Analysis 17.16.1. Value Proportion Analysis by Market Taxonomy 17.16.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2033 17.16.2.1. By Application 17.16.2.2. By Technology 17.16.2.3. By End-use 17.17. UAE Market Analysis 17.17.1. Value Proportion Analysis by Market Taxonomy 17.17.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2033 17.17.2.1. By Application 17.17.2.2. By Technology 17.17.2.3. By End-use 17.18. Spain Market Analysis 17.18.1. Value Proportion Analysis by Market Taxonomy 17.18.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2033 17.18.2.1. By Application 17.18.2.2. By Technology 17.18.2.3. By End-use 17.19. Russia Market Analysis 17.19.1. Value Proportion Analysis by Market Taxonomy 17.19.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2033 17.19.2.1. By Application 17.19.2.2. By Technology 17.19.2.3. By End-use 17.20. Saudi Arabia Market Analysis 17.20.1. Value Proportion Analysis by Market Taxonomy 17.20.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2033 17.20.2.1. By Application 17.20.2.2. By Technology 17.20.2.3. By End-use 17.21. Competition Landscape and Player Concentration in the Country 18. Market Structure Analysis 18.1. Market Analysis by Tier of Companies 18.2. Market Concentration 18.3. Market Share Analysis of Top Players 18.4. Market Presence Analysis 18.4.1. By Regional footprint of Players 18.4.2. Product footprint by Players 19. Competition Analysis 19.1. Competition Dashboard 19.2. Competition Benchmarking 19.3. Competition Deep Dive 19.3.1. Stryker 19.3.1.1. Overview 19.3.1.2. Product Portfolio 19.3.1.3. Sales Footprint 19.3.1.4. Strategy Overview 19.3.2. Medtronic 19.3.2.1. Overview 19.3.2.2. Product Portfolio 19.3.2.3. Sales Footprint 19.3.2.4. Strategy Overview 19.3.3. Johnson & Johnson Services 19.3.3.1. Overview 19.3.3.2. Product Portfolio 19.3.3.3. Sales Footprint 19.3.3.4. Strategy Overview 19.3.4. B. Braun Melsungen AG 19.3.4.1. Overview 19.3.4.2. Product Portfolio 19.3.4.3. Sales Footprint 19.3.4.4. Strategy Overview 19.3.5. Smith+Nephew 19.3.5.1. Overview 19.3.5.2. Product Portfolio 19.3.5.3. Sales Footprint 19.3.5.4. Strategy Overview 20. Assumptions and Acronyms Used 21. Research Methodology
Explore Healthcare Insights
View Reports